Search results summary
From Health Canada
Search criteria
- Status: Select all
- AIG: 0140241001
Search results
Status | DIN | Company | Product | Class | PM See footnote1 | Schedule | # See footnote2 | A.I. name See footnote3 | Strength |
---|---|---|---|---|---|---|---|---|---|
Cancelled Post Market | 02513447 | AMGEN CANADA INC | RIABNI | Human | Yes | Prescription | 1 | RITUXIMAB | 10 MG / ML |
Cancelled Post Market | 02513447 | AMGEN CANADA INC | RIABNI | Human | Yes | Schedule D | 1 | RITUXIMAB | 10 MG / ML |
Marketed | 02241927 | HOFFMANN-LA ROCHE LIMITED | RITUXAN | Human | Yes | Prescription | 1 | RITUXIMAB | 10 MG / ML |
Marketed | 02241927 | HOFFMANN-LA ROCHE LIMITED | RITUXAN | Human | Yes | Schedule D | 1 | RITUXIMAB | 10 MG / ML |
Marketed | 02498316 | SANDOZ CANADA INCORPORATED | RIXIMYO | Human | Yes | Schedule D | 1 | RITUXIMAB | 10 MG / ML |
Marketed | 02498316 | SANDOZ CANADA INCORPORATED | RIXIMYO | Human | Yes | Prescription | 1 | RITUXIMAB | 10 MG / ML |
Marketed | 02495724 | PFIZER CANADA ULC | RUXIENCE | Human | Yes | Prescription | 1 | RITUXIMAB | 10 MG / ML |
Marketed | 02495724 | PFIZER CANADA ULC | RUXIENCE | Human | Yes | Schedule D | 1 | RITUXIMAB | 10 MG / ML |
Marketed | 02478382 | CELLTRION INC. | TRUXIMA | Human | Yes | Schedule D | 1 | RITUXIMAB | 100 MG / 10 ML |
Marketed | 02478382 | CELLTRION INC. | TRUXIMA | Human | Yes | Prescription | 1 | RITUXIMAB | 100 MG / 10 ML |
Marketed | 02478390 | CELLTRION INC. | TRUXIMA | Human | Yes | Prescription | 1 | RITUXIMAB | 500 MG / 50 ML |
Marketed | 02478390 | CELLTRION INC. | TRUXIMA | Human | Yes | Schedule D | 1 | RITUXIMAB | 500 MG / 50 ML |
Application information
Related information
Contact us
Version 4.0.3